Table 3 Associated factors of deprescribing

N

177

Age (years), mean(SD) 

1 (0.98–1.02), 0.821

Sex (Female), n (%) 

1.54 (1.04–2.36), 0.038

1.55 (0.96–2.59), 0.081

MNA, n(%) 

 At risk

1.22 (0.84–1.81), 0.306

 Malnourished

1.66 (0.97–2.79), 0.057

0.9 (0.51–1.54), 0.681

ADL, median(IQR) 

0.84 (0.78–0.91), 0

0.87 (0.78–0.97), 0.014

CCI, median(IQR) 

1.15 (1.07–1.24), 0

0.99 (0.87–1.13), 0.906

Diabetes Mellitus, n(%)

1.12 (0.76–1.6), 0.563

CKD (Moderate-severe), n(%)

1.17 (0.73–1.81), 0.485

CHF, n(%) 

1.53 (0.96–2.33), 0.06

0.91 (0.5–1.63), 0.733

Myocardial Infarction, n(%)

0.85 (0.54–1.29), 0.459

COPD, n(%)

0.91 (0.49–1.56), 0.751

Peripheral vascular disease, n(%)

1.64 (1.09–2.42), 0.015

1.47 (0.83–2.55), 0.16

Dementia, n(%) 

1.72 (1.24–2.38), 0.001

1.18 (0.72–1.93), 0.499

Setting at discharge, n(%)

 Rehabilitation

0.93 (0.63–1.38), 0.696

Delirium in 72h after surgery, n(%)

2.14 (1.56–2.93), 0

1.71 (1.09–2.66), 0.017

N Drugs at admission, median(IQR)

1.15 (1.09–1.21), 0

1.15 (1.03–1.29), 0

Polypharmacy >5 at admission, n(%)

2.32 (1.69–3.2), 0

Enrolling centers^a

 01

ref

ref

 02

1.67 (0.95–2.87), 0.069

2.65 (1.19–5.74), 0.013

 04

1.45 (0.9–2.33), 0.123

1.12 (0.62–1.97), 0.716

 06

0.99 (0.42–2.1), 0.984

0.94 (0.38–2.07), 0.881

 08

0.7 (0.44–1.12), 0.133

0.6 (0.34–1.04), 0.052

 10

0.2 (0.06–0.51), 0.003

0.15 (0.04–0.41), 0.001

 13

0.69 (0.2–1.78), 0.487

1.18 (0.33–3.34), 0.767